{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:28:12Z","timestamp":1759480092254,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1053\/j.ajkd.2021.05.025","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T18:50:55Z","timestamp":1634842255000},"page":"A16-A18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic Acidosis and Hyponatremia in a Patient With Metastatic Melanoma"],"prefix":"10.1053","volume":"78","author":[{"given":"Dayyan","family":"Adoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsa","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Mustaqeem","key":"10.1053\/j.ajkd.2021.05.025_bib1"},{"key":"10.1053\/j.ajkd.2021.05.025_bib2","doi-asserted-by":"crossref","unstructured":"El Bitar S, Weerasinghe C, El-Charabaty E, Odaimi M. Renal tubular acidosis an adverse effect of PD-1 inhibitor immunotherapy. Case Rep Oncol Med. 2018 Jan 31;2018:8408015. doi:10.1155\/2018\/8408015","DOI":"10.1155\/2018\/8408015"},{"issue":"5","key":"10.1053\/j.ajkd.2021.05.025_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.xkme.2020.05.015","article-title":"Renal tubular acidosis and immune checkpoint inhibitor therapy: an immune-related adverse event of PD-1 inhibitor - a report of 3 cases","volume":"2","author":"Herrmann","year":"2020","journal-title":"Kidney Med"},{"issue":"1","key":"10.1053\/j.ajkd.2021.05.025_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ckj\/sfz051","article-title":"A\u00a0new expression of immune checkpoint inhibitors' renal toxicity: when distal tubular acidosis precedes creatinine elevation","volume":"13","author":"Charmetant","year":"2019","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1053\/j.ajkd.2021.05.025_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/2399369321992776","article-title":"A\u00a0case of pembrolizumab induced distal renal tubular acidosis","volume":"5","author":"Atiq","year":"2021","journal-title":"Journal of Onco-Nephrology"},{"issue":"2","key":"10.1053\/j.ajkd.2021.05.025_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1139","key":"10.1053\/j.ajkd.2021.05.025_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/postgradmedj-2019-137297","article-title":"Acute hyponatremia from immune checkpoint inhibitor therapy for\u00a0non-small cell lung cancer","volume":"96","author":"Desikan","year":"2020","journal-title":"Postgrad Med J"},{"key":"10.1053\/j.ajkd.2021.05.025_bib8","article-title":"Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors","author":"Seethapathy","year":"2020","journal-title":"Nephrol Dial Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621007885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621007885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:41:38Z","timestamp":1759462898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638621007885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0272638621007885"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.05.025","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Acidosis and Hyponatremia in a Patient With Metastatic Melanoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}